Patents by Inventor Woong-Kyung Suh

Woong-Kyung Suh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Downregulation of immune response by administering B7RP-2 fusion protein
    Patent number: 7482325
    Abstract: The present invention provides B7 Related Protein-2 (B7RP-2) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing B7RP-2 polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with B7RP-2 polypeptides.
    Type: Grant
    Filed: September 16, 2005
    Date of Patent: January 27, 2009
    Assignee: Amgen Inc.
    Inventors: Steven Kiyoshi Yoshinaga, Woong-Kyung Suh, Tak Wah Mak
  • B7 related protein-2 molecules and uses thereof
    Publication number: 20060269565
    Abstract: The present invention provides B7 Related Protein-2 (B7RP-2) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing B7RP-2 polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with B7RP-2 polypeptides.
    Type: Application
    Filed: September 16, 2005
    Publication date: November 30, 2006
    Inventors: Steven Yoshinaga, Woong-Kyung Suh, Tak Mak
  • B7 related protein-2 molecules and uses thereof
    Publication number: 20030039999
    Abstract: The present invention provides B7 Related Protein-2 (B7RP-2) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing B7RP-2 polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with B7RP-2 polypeptides.
    Type: Application
    Filed: May 28, 2002
    Publication date: February 27, 2003
    Applicant: Amgen, Inc.
    Inventors: Steven Kiyoshi Yoshinaga, Woong-Kyung Suh, Tak Wah Mak